Medicine | Page 298 of 378 | SpiritIndia.com

Muscular Dystrophy :: Drug Trichostatin A (TSA) Can Counteract Muscular Dystrophy

Scientists at the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) and other institutions have demonstrated for the first time that a single drug can rebuild damaged muscle in two strains of mice that develop diseases comparable to two human forms of muscular dystrophy. This advance, which is reported online in Nature Medicine, is the latest from a research collaboration that began several years ago by the teams of Vittorio Sartorelli, M.D., at NIAMS and Pier Lorenzo Puri, M.D., Ph.D., now at Dulbecco Telethon Institute (DTI) in Rome, Italy and The Burnham Institute in La Jolla, Calif.

Cancer :: Agennix receives fda orphan drug designation for talactoferrin alfa in renal cell carcinoma

Agennix today announced that the U.S. Food and Drug Administration (FDA) has granted orphan drug designation to the Company’s oral formulation of Talactoferrin Alfa (talactoferrin or TLF) for the treatment of renal cell carcinoma (RCC). Oral TLF is currently in Phase II clinical development for RCC. Results from a multi-center Phase 2 RCC trial that included six leading U.S. cancer centers were presented at the 2006 Annual meeting of the American Society of Clinical Oncology (ASCO).

Obesity :: Manhattan pharmaceuticals – oral oleoyl-estrone clinical program to include morbidly obese

Manhattan Pharmaceuticals, Inc. (Amex: MHA) today announced expansion of its oral Oleoyl-estrone (OE) clinical obesity program to include the morbidly obese. A new US Phase 2a clinical trial evaluating oral OE in morbidly obese male subjects will be initiated in October 2006. The morbidly obese population in the US is estimated to be 14 million people. OE is the Company’s orally administered product candidate in development for the treatment of obesity.

Malaria :: John mcneil named scientific director of path malaria vaccine initiative

The PATH Malaria Vaccine Initiative today announced the appointment of John G. McNeil, MD, MPH, as scientific director, effective immediately. Dr. McNeil will have principal responsibility for directing MVI’s early-stage vaccine development efforts and for shaping and managing MVI’s overall candidate vaccine portfolio.

Chikungunya :: Treating chikungunya with Ayurveda, Siddha

While the Allopathic system seems to have no medicine or treatment to cure or prevent the disease, or take care of the after-effects – most importantly severe joint pains – Ayurveda / Siddha Physicians have been routinely treating this fever.

Breast Cancer :: Breast cancer risk dependent upon ethnic variations in hormone levels

Researchers have known that a woman’s natural hormone levels can affect her risk of developing breast cancer. A new study from the University of Southern California (USC) has found that the natural levels of estrogens in post-menopausal women varies by ethnicity and race, and may explain the differences in the groups’ breast cancer rates. The study appears in the October issue of Cancer Epidemiology, Biomarkers & Prevention.

COPD :: Copd patients with acid reflux twice as likely to experience exacerbations

A new study shows an association between acid reflux symptoms and chronic obstructive pulmonary disease (COPD) exacerbations. Using a questionnaire-based, cross-sectional survey, researchers from the University of Florida, Jacksonville, investigated the prevalence and effect of acid reflux symptoms, formally known as gastroesophageal reflux disease (GERD), on the rate of exacerbations in 86 patients with COPD (57 percent men, mean age 67.5 years).

Asthma :: Mutual recognition procedure for Symbicort maintenance n reliever therapy Symbicort smart

AstraZeneca announced that it has successfully completed the European Union Mutual Recognition Procedure (MRP) for Symbicort? Maintenance And Reliever Therapy (Symbicort SMART?). This new asthma treatment approach allows patients to use just one inhaler for both maintenance and relief of asthma symptoms.

Nutrition :: Researchers look to solve mystery behind egcg and probiotics

When talking about nutrition, EGCG and probiotics are two words that we’ve been hearing a lot about these days. But most consumers don’t know what they are, where they are found and what they do. Some of that mystery was cleared up this week at the 47th Annual Symposia of the American College of Nutrition (ACN) where leading nutrition experts revealed new research about the health benefits of these two ingredients.

Dengue Fever :: Liquid diet recommended in dengue fever – Yoga and Naturopathy

According to Naturopaths the energy needed for digestion if diverted to elimination can benefit those affected with dengue. “A dengue affected person is put on complete liquid diet. The affected person may be given fruit juice, vegetable soups but no solid diet, neither solid fruit. Thus the energy required for digestion is diverted towards elimination,” Central Council for Research in Yoga and Naturopathy Assistant Director Dr Rajiv Rastogi said.